IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition
Michaele J. Armstrong(University of Pittsburgh), John H. Yim(City of Hope)
Cited by 35
Related Papers
Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer
|Molecular Cancer|2015|93
Combination therapy with BYL719 and LEE011 is synergistic and causes a greater suppression of p-S6 in triple negative breast cancer
|Scientific Reports|2019|33
Therapeutic Potential of Baicalein in Endometrial Cancer: Suppression of mTOR Signaling and Synergy with Metformin
|International Journal of Molecular Sciences|2025|2
Mechanisms of IRF-1 Induced Cancer Growth Inhibition
|D-Scholarship@Pitt (University of Pittsburgh)|2006|0